Ayurcann Holdings Corp. (AYUR.CN)
CAD 0.03
(0.0%)
CAD 0.03
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -2.01 Million CAD | 51.49% |
| 2022 | -4.49 Million CAD | -39.37% |
| 2021 | -3.01 Million CAD | -216.97% |
| 2020 | 653.98 Thousand CAD | 1138.65% |
| 2019 | -244.78 Thousand CAD | -2.01% |
| 2018 | -239.96 Thousand CAD | 15.73% |
| 2017 | -272.77 Thousand CAD | -30.01% |
| 2016 | -219.02 Thousand CAD | 34.63% |
| 2015 | -335.07 Thousand CAD | -34.31% |
| 2014 | -249.47 Thousand CAD | -106.17% |
| 2013 | 4.04 Million CAD | 876.35% |
| 2012 | -520.47 Thousand CAD | -411.9% |
| 2011 | -101.67 Thousand CAD | -1395.22% |
| 2010 | -6800.00 CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q1 | 172.38 Thousand CAD | 106.75% |
| 2023 Q3 | 36.12 Thousand CAD | 115.16% |
| 2023 Q4 | -1.97 Million CAD | -5579.49% |
| 2023 Q2 | -238.32 Thousand CAD | -238.25% |
| 2022 FY | - CAD | -39.37% |
| 2022 Q4 | -2.55 Million CAD | -208.51% |
| 2022 Q3 | -827.21 Thousand CAD | -989.92% |
| 2022 Q2 | 92.95 Thousand CAD | 111.05% |
| 2022 Q1 | -841.43 Thousand CAD | 68.17% |
| 2021 Q3 | -456.1 Thousand CAD | -268.82% |
| 2021 Q4 | -2.64 Million CAD | -479.52% |
| 2021 Q2 | -123.66 Thousand CAD | -147.78% |
| 2021 Q1 | 258.83 Thousand CAD | -92.61% |
| 2021 FY | - CAD | -216.97% |
| 2020 Q4 | 3.5 Million CAD | 494.31% |
| 2020 Q1 | -62.49 Thousand CAD | -35.39% |
| 2020 Q2 | -40.4 Thousand CAD | 35.34% |
| 2020 FY | - CAD | 1138.65% |
| 2020 Q3 | -887.8 Thousand CAD | -2097.22% |
| 2019 FY | - CAD | -2.01% |
| 2019 Q4 | -46.15 Thousand CAD | 25.91% |
| 2019 Q3 | -62.29 Thousand CAD | 23.71% |
| 2019 Q2 | -81.66 Thousand CAD | -23.14% |
| 2019 Q1 | -66.31 Thousand CAD | -30.97% |
| 2018 Q4 | -50.63 Thousand CAD | 5.25% |
| 2018 Q3 | -53.44 Thousand CAD | 38.36% |
| 2018 Q2 | -86.7 Thousand CAD | 34.95% |
| 2018 Q1 | -133.28 Thousand CAD | -174.97% |
| 2018 FY | - CAD | 15.73% |
| 2017 Q3 | -56.96 Thousand CAD | 1.79% |
| 2017 FY | - CAD | -30.01% |
| 2017 Q4 | -48.47 Thousand CAD | 14.91% |
| 2017 Q2 | -58 Thousand CAD | 8.98% |
| 2017 Q1 | -63.72 Thousand CAD | -7.06% |
| 2016 Q1 | -179.66 Thousand CAD | -285.09% |
| 2016 Q3 | -45.84 Thousand CAD | 8.16% |
| 2016 Q4 | -59.52 Thousand CAD | -29.84% |
| 2016 Q2 | -49.92 Thousand CAD | 72.21% |
| 2016 FY | - CAD | 34.63% |
| 2015 FY | - CAD | -34.31% |
| 2015 Q3 | -53.9 Thousand CAD | 1.73% |
| 2015 Q4 | -46.65 Thousand CAD | 13.45% |
| 2015 Q2 | -54.85 Thousand CAD | -35.99% |
| 2015 Q1 | -40.33 Thousand CAD | 18.03% |
| 2014 Q2 | -98.42 Thousand CAD | -102.25% |
| 2014 Q3 | -61.5 Thousand CAD | 37.51% |
| 2014 Q1 | 4.37 Million CAD | 4341.9% |
| 2014 Q4 | -49.2 Thousand CAD | 19.99% |
| 2014 FY | - CAD | -106.17% |
| 2013 Q3 | -96.09 Thousand CAD | 26.9% |
| 2013 Q2 | -131.45 Thousand CAD | -104.05% |
| 2013 Q4 | -103.05 Thousand CAD | -7.24% |
| 2013 Q1 | -64.42 Thousand CAD | 51.27% |
| 2013 FY | - CAD | 876.35% |
| 2012 Q4 | -132.19 Thousand CAD | 25.53% |
| 2012 Q3 | -177.5 Thousand CAD | -14.44% |
| 2012 Q2 | -155.11 Thousand CAD | 88.48% |
| 2012 Q1 | -1.34 Million CAD | -735.14% |
| 2012 FY | - CAD | -411.9% |
| 2011 FY | - CAD | -1395.22% |
| 2011 Q4 | -161.2 Thousand CAD | -119.16% |
| 2011 Q3 | 841.57 Thousand CAD | 2751.72% |
| 2011 Q1 | -6974.00 CAD | 57.57% |
| 2011 Q2 | -31.73 Thousand CAD | -355.08% |
| 2010 FY | - CAD | 0.0% |
| 2010 Q4 | -16.43 Thousand CAD | 64.67% |
| 2010 Q3 | -46.52 Thousand CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aion Therapeutic Inc. | -6.07 Million CAD | 66.898% |
| Blueberries Medical Corp. | -1.22 Million CAD | -64.553% |
| The BC Bud Corporation | -1.19 Million CAD | -68.099% |
| BioNxt Solutions Inc. | -6.48 Million CAD | 68.996% |
| CordovaCann Corp. | -1.6 Million CAD | -25.45% |
| Christina Lake Cannabis Corp. | -2.62 Million CAD | 23.365% |
| Captor Capital Corp. | 2.42 Million CAD | 183.038% |
| City View Green Holdings Inc. | -2.01 Million CAD | 0.197% |
| 1CM Inc. | 1.31 Million CAD | 253.061% |
| Global Hemp Group Inc. | -24.79 Thousand CAD | -8009.111% |
| Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | 8.961% |
| IM Cannabis Corp. | -2.79 Million CAD | 27.939% |
| Lobe Sciences Ltd. | -4.4 Million CAD | 54.331% |
| Maple Leaf Green World Inc. | -392.21 Thousand CAD | -412.598% |
| Mountain Valley MD Holdings Inc. | -3.19 Million CAD | 37.034% |
| Nextleaf Solutions Ltd. | 1.14 Million CAD | 276.112% |
| Ovation Science Inc. | -778.83 Thousand CAD | -158.142% |
| Pharmadrug Inc. | -1.33 Million CAD | -50.597% |
| Captiva Verde Wellness Corp. | -6.05 Million CAD | 66.802% |
| RAMM Pharma Corp. | -6.3 Million CAD | 68.098% |
| RIV Capital Inc. | -20.28 Million CAD | 90.087% |
| Revive Therapeutics Ltd. | -5.59 Million CAD | 64.066% |
| Red White & Bloom Brands Inc. | -77.59 Million CAD | 97.409% |
| SLANG Worldwide Inc. | -2.95 Million CAD | 31.864% |
| 1933 Industries Inc. | -10.03 Million CAD | 79.961% |
| Red Light Holland Corp. | -5.25 Million CAD | 61.748% |
| Top Strike Resources Corp. | -767.99 Thousand CAD | -161.785% |
| Xebra Brands Ltd. | -1.49 Million CAD | -34.481% |
| Adastra Holdings Ltd. | -1.41 Million CAD | -42.46% |